glp-1 drug companies Swiss Re says drugs could reduce US mortality by up to 6.4% GLP-1 Drugs from the Gray
Description
Theyre serious medications with strict usage requirements that are intended for chronic weight management
Semaglutide, a GLP-1 receptor agonist, has been proven to help individuals lose weight by regulating appetite, reducing food cravings, and promoting better blood sugar control
Available from: [Google Scholar] 50.Finan B, Ma T, Ottaway N, Muller TD, Habegger KM, Heppner KM, et al
No medical or veterinary claims are made
A separate study found most people who stop taking GLP-1s regain 60% of the weight they lost within a year, and eventually 75% of it, only shedding 25% of that weight in the long term
